Free Access
| Issue |
Med Sci (Paris)
Volume 41, Novembre 2025
Les Cahiers de Myologie
|
|
|---|---|---|
| Page(s) | 82 - 84 | |
| Section | Histoire | |
| DOI | https://doi.org/10.1051/medsci/2025196 | |
| Published online | 28 November 2025 | |
- Fardeau M, Godet-Guillain J, Tome FM, et al. [A new familial muscular disorder demonstrated by the intra-sarcoplasmic accumulation of a granulo-filamentous material which is dense on electron microscopy (author’s transl)]. Rev Neurol. (Paris) 1978 ; 134 : 411–425. [Google Scholar]
- Claeys KG, Fardeau M, Schröder R, et al. Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene. Neuromuscul Disord. 2008 ; 18 : 656–666. [Google Scholar]
- Fardeau M, Hillaire D, Mignard C, et al. Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain 1996 ; 119 (Pt 1) : 295–308. [Google Scholar]
- Tomé FM, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III 1994 ; 317 : 351–357. [Google Scholar]
- Fardeau M, Matsumura K, Tomé FM, et al. Deficiency of the 50 kDa dystrophin associated glycoprotein (adhalin) in severe autosomal recessive muscular dystrophies in children native from European countries. C R Acad Sci III 1993 ; 316 : 799–804. [Google Scholar]
- Eymard B, Romero NB, Leturcq F, et al. Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology 1997 ; 48 : 1227–1234. [Google Scholar]
- Jeannet P-Y, Bassez G, Eymard B, et al. Clinical and histologic findings in autosomal centronuclear myopathy. Neurology 2004 ; 62 : 1484–1490. [Google Scholar]
- Bitoun M, Maugenre S, Jeannet P-Y, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet. 2005 ; 37 : 1207–1209. [Google Scholar]
- Fardeau M. Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. Part III. Ethical considerations. Neuromuscul Disord. 2002 ; 12 Suppl 1 : S52–54. [Google Scholar]
- Romero NB, Benveniste O, Payan C, et al. Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/ Becker muscular dystrophies. Part II: clinical protocol. Neuromuscul Disord. 2002 ; 12 Suppl 1 : S45–48. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.